Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of parvovirus for eliminating cancer stem cells (CSCs)

Use of parvovirus for eliminating cancer stem cells (CSCs)

US Patent 10525091 · Granted Jan 7, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Optimized parvovirus H-1 production2025
Optimized parvovirus H-1 production2025
Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor2024
Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor2024
Parvovirus formulation for treating tumors2022
Parvovirus formulation for treating tumors2022
Parvovirus formulation for treating tumors2022
Scalable process for oncolytic rat parvovirus H-1 production and purification ba2021
Scalable process for oncolytic rat parvovirus H-1 production and purification ba2021
Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor2021
Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor2021
Cancer therapy with a parvovirus combined with bevacizumab2020